PYC taps investors for $75m

14/03/2024 - 16:06


Upgrade your subscription to use this feature.

PYC Therapeutics is rattling the tin for up to $74.6 million to fund the progress of its medical drug trials, including for blinding eye and polycystic kidney diseases.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options